Regulation of nicotinic receptors in the brain of mice withdrawn from chronic oral nicotine treatment
Abstract
The effect of nicotine withdrawal on regional regulation of brain nicotinic receptors was studied in mice after chronic administration of nicotine in the drinking water for 2, 4 or 7 weeks. Two weeks of chronic nicotine administration did not alter the binding of [3H]-nicotine in the midbrain, cortex or cerebellum of the mice, while after both 4-and 7-week treatments a significant increase in the specific [3H]-nicotine binding was observed in cortical and midbrain membranes. In the midbrain, the [3H]-nicotine binding was increased by about 40% in mice withdrawn for 48-72 h from the 4-week chronic nicotine treatment and in mice withdrawn for 48 h from the 7-week treatment. The [3H]-nicotine binding was significantly increased (by 55-65%) in the cortex at 48 h and 72 h after withdrawal from 4-week chronic nicotine and it was even somewhat more increased (by 72-66%) after 7-week treatment. The cortical [3H]-nicotine binding was not altered at 24 h after the 4-week treatment, but in mice withdrawn for 24 h from the 7-week treatment it was increased by 116%. The increases in [3H]-nicotine binding returned to control levels within 1 week after withdrawal. None of the studied treatments affected the [3H]-nicotine binding in the cerebellum. Tolerance towards nicotine-induced locomotor depression was only found in mice withdrawn for 24 h from the 7-week chronic nicotine administration. These findings suggest that at least 4-week chronic nicotine administration in the drinking water is needed before any upregulation of nicotinic receptors can be observed. Furthermore, in our experiments the increase in the [3H]-nicotine binding was seen before behavioural tolerance could be demonstrated. The differences between brain regions in the time course of nicotinic receptor upregulation may reflect variations in nicotinic receptor subunits and their sensitivity to chronic nicotine treatment.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Preclinical studies have demonstrated that nAChR levels return to control levels after termination of nicotine exposure, but with great variability in the time course.
“Preclinical studies have demonstrated that nAChR levels return to control levels after termination of nicotine exposure, but with great variability in the time course15-17.”
From β2-Nicotinic Acetylcholine Receptor Availability During Acute and Prolonged Abstinence From Tobacco Smoking (2009) · cites this paper as [15]
Previous preclinical studies demonstrated that in chronically nicotine treated animals, nAChR levels returned to levels observed in control animals after termination of nicotine, but with variable timing ranging between 1 and 3 weeks.
“Previous preclinical studies demonstrated that in chronically nicotine treated animals, nAChR levels returned to levels observed in control animals after termination of nicotine, but with variable timing ranging between 1 and 3 weeks15, 80, 81.”
From β2-Nicotinic Acetylcholine Receptor Availability During Acute and Prolonged Abstinence From Tobacco Smoking (2009) · cites this paper as [15]
Upregulation of nAChR expression can persist for several days after termination of chronic nicotine.
“Additionally, studies have demonstrated that upregulation of nAChR expression can persist for several days following termination of chronic nicotine (Pietila et al. 1998; Staley et al. 2006).”
From Nicotine Withdrawal (2015) · cites this paper as Pietila et al. 1998
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 315,771 · see citing works
Presynaptic nicotinic ACh receptors
Wonnacott, S. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)10073-4 · Cited by 1,308 · see citing works
The Diversity of Neuronal Nicotinic Acetylcholine Receptors
Sargent, P. B. (1993) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.16.030193.002155 · Cited by 1,052 · see citing works
Wada, E., Wada, K., Boulter, J., Deneris, E. S., Heinemann, S., Patrick, J., & Swanson, L. W. (1989) · The Journal of Comparative Neurology · doi:10.1002/cne.902840212 · Cited by 1,044 · see citing works
Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment
Marks, M., Pauly, Jr., Gross, S., Deneris, E., Hermans-Borgmeyer, I., Heinemann, S., & Collins, A. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-07-02765.1992 · Cited by 551 · see citing works
Nicotinic Cholinergic Receptor Binding Sites in the Brain: Regulation in Vivo
Schwartz, R. D., & Kellar, K. J. (1983) · Science · doi:10.1126/science.6828889 · Cited by 479 · see citing works
Effects of chronic nicotine infusion on tolerance development and nicotinic receptors
Marks, M. J., Burch, J. B., & Collins, A. C. (1983) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21831-6 · Cited by 464 · see citing works
The effects of nicotine on locomotor activity in non‐tolerant and tolerant rats
Clarke, P. B. S., & Kumar, R. (1983) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1983.tb09398.x · Cited by 457 · see citing works
Peng, X., Gerzanich, V, Anand, R., Whiting, P. J., & Lindstrom, J. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09730-5 · Cited by 391 · see citing works
The paradox of nicotinic acetylcholine receptor upregulation by nicotine
Wonnacott, S. (1990) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(90)90242-z · Cited by 357 · see citing works
Grady, S., Marks, M. J., Wonnacott, S., & Collins, A. C. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08322.x · Cited by 350 · see citing works
Fenster, C. P., Rains, M. F., Noerager, B., Quick, M. W., & Lester, R. A. J. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-15-05747.1997 · Cited by 332 · see citing works
In Vivo Regulation of [3H]Acetylcholine Recognition Sites in Brain by Nicotinic Cholinergic Drugs
Schwartz, R. D., & Kellar, K. J. (1985) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1985.tb04005.x · Cited by 282 · see citing works
Time course study of the effects of chronic nicotine infusion on drug response and brain receptors
Marks, M. J., Stitzel, J. A., & Collins, A. C. (1985) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24213-6 · Cited by 265 · see citing works
Ksir, C., Hakan, R., Hall, D. P., & Kellar, K. J. (1985) · Neuropharmacology · doi:10.1016/0028-3908(85)90058-9 · Cited by 204 · see citing works
Downregulation of nicotinic receptor function after chronic nicotine infusion.
Marks, M. J., Grady, S. R., & Collins, A. C. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39368-7 · Cited by 190 · see citing works
Petersen, D. R., Norris, K. J., & Thompson, J. A. (1984) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)07789-x · Cited by 160 · see citing works
The Pharmacology of (-)-Nicotine and Novel Cholinergic Channel Modulators
Brioni, J. D., Decker, M. W., Sullivan, J. P., & Arnerić, S. P. (1996) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60950-3 · Cited by 134 · see citing works
Genotype influences the development of tolerance to nicotine in the mouse.
Marks, M. J., Campbell, S. M., Romm, E., & Collins, A. C. (1991) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20539-0 · Cited by 105 · see citing works
Nicotine-induced tolerance and receptor changes in four mouse strains
Marks, M. J., Romm, E., Gaffney, D. K., & Collins, A. C. (1986) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)25031-5 · Cited by 83 · see citing works
Collins, A. C., Romm, E., & Wehner, J. M. (1990) · Brain Research Bulletin · doi:10.1016/0361-9230(90)90222-l · Cited by 79 · see citing works
Tolerance to nicotine following chronic treatment by injections: a potential role for corticosterone
Pauly, J. R., Grun, E. U., & Collins, A. C. (1992) · Psychopharmacology · doi:10.1007/bf02245282 · Cited by 73 · see citing works
Comparative Analysis of Nicotine‐Like Receptor‐Ligand Interactions in Rodent Brain Homogenate
Larsson, C. U., & Nordberg, A. K. (1985) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1985.tb05469.x · Cited by 67 · see citing works
Self-citationNicotine tolerance: an analysis of the time course of its development and loss in the rat
Collins, A. C., Romm, E., & Wehner, J. M. (1988) · Psychopharmacology · doi:10.1007/bf02431526 · Cited by 66 · see citing works
Influences of genotype and sex on behavioral tolerance to nicotine in mice
Hatchell, P. C., & Collins, A. C. (1977) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(77)90156-3 · Cited by 65 · see citing works
Pekonen, K., Karlsson, C., Laakso, I., & Ahtee, L. (1993) · European Journal of Pharmaceutical Sciences · doi:10.1016/0928-0987(93)90013-z · Cited by 60 · see citing works
Self-citationZhang, X. L., & Nordberg, A. K. (1993) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00168533 · Cited by 51 · see citing works
Self-citationZhang, X., Gong, Z., & Nordberg, A. K. (1994) · Brain Research · doi:10.1016/0006-8993(94)90343-3 · Cited by 49 · see citing works
Self-citationChronic nicotine exposure in rat: A behavioural and biochemical study of tolerance
Falkeborn, Y., Larsson, C. U., & Nordberg, A. K. (1981) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(81)90086-7 · Cited by 45 · see citing works
Self-citationEffect of nicotine pretreatment on striatal dopaminergic system in rats
Fung, Y. K., & Lau, Y. (1989) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(89)90237-2 · Cited by 42 · see citing works
Pietil�, K., Laakso, I., & Ahtee, L. (1995) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00168923 · Cited by 40 · see citing works
Self-citationDeterminants of nicotine self-administration
Shoaib, M. C. (1996) · Drug Development Research · doi:10.1002/(sici)1098-2299(199607/08)38:3/4 · Cited by 7 · see citing works
Flagged first, then by citations
1 of the 33 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Staley, J. K., Krishnan-Sarin, S., Cosgrove, K. P., Krantzler, E., Frohlich, E., Perry, E., Dubin, J. A., Estok, K., Brenner, E., Baldwin, R. M., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0546-06.2006 · Cited by 223 · see citing works
“Nicotine was administered orally using the dose escalation paradigm described previously (Pietila et al., 1998).”
MethodSmoking, nicotine and neuropsychiatric disorders
Döme, P., Lazáry, J., Kalapos, M. P., & Rihmer, Z. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.07.013 · Cited by 215 · see citing works
Neural Systems Governed by Nicotinic Acetylcholine Receptors: Emerging Hypotheses
Miwa, J. M., Freedman, R., & Lester, H. A. (2011) · Neuron · doi:10.1016/j.neuron.2011.03.014 · Cited by 205 · see citing works
Barnes, C. A., Meltzer, J., Houston, F. P., Orr, G. W., McGann, K., & Wenk, G. L. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00180-9 · Cited by 193 · see citing works
Galantamine: Effect on nicotinic receptor binding, acetylcholinesterase inhibition, and learning
Woodruff‐Pak, D. S., Vogel, R. W., & Wenk, G. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.2089 · Cited by 189 · see citing works
Defining nicotine dependence for genetic research: evidence from Australian twins
LESSOV, C. N., MARTIN, N. G., STATHAM, D. J., TODOROV, A. A., SLUTSKE, W. S., BUCHOLZ, K. K., HEATH, A. C., & MADDEN, P. A. F. (2004) · Psychological Medicine · doi:10.1017/s0033291703001582 · Cited by 185 · see citing works
McLaughlin, I., Dani, J. A., & De Biasi, M. (2015) · Current Topics in Behavioral Neurosciences · doi:10.1007/978-3-319-13482-6_4 · Cited by 173 · see citing works
“Additionally, studies have demonstrated that upregulation of nAChR expression can persist for several days following termination of chronic nicotine (Pietila et al. 1998; Staley et al. 2006).”
BackgroundCosgrove, K. P., Batis, J., Bois, F., Maciejewski, P. K., Esterlis, I., Kloczynski, T., Stiklus, S., Krishnan-Sarin, S., O’Malley, S., Perry, E., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.41 · Cited by 159 · see citing works
Brown, R. W., & Kolb, B. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02201-6 · Cited by 156 · see citing works
Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse
Korpi, E. R., den Hollander, B., Farooq, U., Vashchinkina, E., Rajkumar, R., Nutt, D. J., Hyytiä, P., & Dawe, G. S. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010967 · Cited by 148 · see citing works
Görlich, A., Antolin‐Fontes, B., Ables, J. L., Frahm, S., Ślimak, M. A., Dougherty, J. D., & Ibáñez-Tallon, I. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1313103110 · Cited by 109 · see citing works
Inside-out neuropharmacology of nicotinic drugs
Henderson, B. J., & Lester, H. A. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.01.022 · Cited by 102 · see citing works
Lemay, S., Chouinard, S., Blanchet, P. J., Masson, H., Soland, V., Beuter, A. C., & Bédard, M. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(03)00172-6 · Cited by 99 · see citing works
Nicotine physical dependence and tolerance in the mouse following chronic oral administration
Grabus, S. D., Martin, B. R., Batman, A. M., Tyndale, R. F., Sellers, E. M., & Damaj, M. I. (2004) · Psychopharmacology · doi:10.1007/s00213-004-2007-3 · Cited by 97 · see citing works
Temporal Change in Human Nicotinic Acetylcholine Receptor After Smoking Cessation: 5IA SPECT Study
Mamede, M., Ishizu, K., Ueda, M., Mukai, T., Iida, Y., Kawashima, H., Fukuyama, H., Togashi, K., & Saji, H. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.043471 · Cited by 90 · see citing works
Rodent models of nicotine withdrawal syndrome
Malin, D. H., & Goyarzu, P. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-69248-5_14 · Cited by 89 · see citing works
Turner, J. R., Castellano, L. M., & Blendy, J. A. (2011) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntq206 · Cited by 78 · see citing works
McCallum, S. E., Collins, A. C., Paylor, R. E., & Marks, M. J. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0076-6 · Cited by 72 · see citing works
Rodent models for nicotine withdrawal
Chellian, R., Behnood‐Rod, A., Bruijnzeel, D. M., Wilson, R., Pandy, V., & Bruijnzeel, A. W. (2021) · Journal of Psychopharmacology · doi:10.1177/02698811211005629 · Cited by 68 · see citing works
Mu‐opioid receptors are involved in the tolerance to nicotine antinociception
Galeote, L., Kieffer, B. L., Maldonado, R. J., & Berrendero, F. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03751.x · Cited by 65 · see citing works
Varenicline ameliorates nicotine withdrawal-induced learning deficits in C57BL/6 mice.
Raybuck, J. D., Portugal, G. S., Lerman, C., & Gould, T. J. (2008) · Behavioral Neuroscience · doi:10.1037/a0012601 · Cited by 62 · see citing works
Nicotinic Acetylcholine Receptor Signaling in Neuroprotection
Akaike, A., Shimohama, S., & Misu, Y. (2018) · Springer eBooks · doi:10.1007/978-981-10-8488-1 · Cited by 60 · see citing works
Gäddnäs, H., Pietilä, K., & Ahtee, L. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00201-1 · Cited by 60 · see citing works
Self-citationMarttila, K., Raattamaa, H., & Ahtee, L. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.02.014 · Cited by 59 · see citing works
Self-citationKivinummi, T., Kaste, K., Rantamäki, T., Ċastrén, E., & Ahtee, L. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.01.015 · Cited by 57 · see citing works
Self-citationGould, T. J., Portugal, G. S., André, J. M., Tadman, M. P., Marks, M. J., Kenney, J. W., Yildirim, E., & Adoff, M. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.01.003 · Cited by 56 · see citing works
“In vivo, Pietilä et al. (1998) found that a 7 week chronic nicotine treatment produced an increase in cortical nAChR binding that lasted over 3 days after cessation of chronic treatment but tolerance to the acute locomotor stimulatory effects of nicotine only lasted 1 day.”
Chronic nicotine administration in the drinking water affects the striatal dopamine in mice
Pietilä, K., & Ahtee, L. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00235-5 · Cited by 50 · see citing works
Self-citationAssociative Learning, the Hippocampus, and Nicotine Addiction
Gould, T. J., & Davis, J. A. (2008) · Current Drug Abuse Reviews · doi:10.2174/1874473710801010009 · Cited by 49 · see citing works
Long-term nicotine exposure reduces Purkinje cell number in the adult rat cerebellar vermis
Chen, W. A., Edwards, R. B., Romero, R. D., Parnell, S. E., & Monk, R. J. (2003) · Neurotoxicology and Teratology · doi:10.1016/s0892-0362(02)00350-1 · Cited by 48 · see citing works
Reward Sensitization: Effects of Repeated Nicotine Exposure and Withdrawal in Mice
Hilário, M. R. F., Turner, J. R., & Blendy, J. A. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.130 · Cited by 48 · see citing works
Agatsuma, S., Lee, M.-S., Zhu, H., Chen, K., Shih, J. C., Seif, I., & Hiroi, N. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl206 · Cited by 47 · see citing works
McCallum, S. E., Parameswaran, N., Bordia, T., Fan, H., Tyndale, R. F., Langston, J. W., McIntosh, J. M., & Quik, M. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03646.x · Cited by 44 · see citing works
Vihavainen, T., Piltonen, M., Tuominen, R. K., Korpi, E. R., & Ahtee, L. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.03.028 · Cited by 43 · see citing works
Self-citationZhu, H., Lee, M.-S., Agatsuma, S., & Hiroi, N. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm027 · Cited by 39 · see citing works
Nicotine facilitates memory consolidation in perceptual learning
Beer, A., Vartak, D., & Greenlee, M. W. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.06.019 · Cited by 35 · see citing works
Gäddnäs, H., Pietilä, K., Piepponen, P. T., & Ahtee, L. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00640-2 · Cited by 35 · see citing works
Self-citationChistyakov, V., Patkina, N. A., Tammimäki, A., Talka, R., Salminen, O., Владимировна, Б. И., Леонидович, Г. Т., Tuominen, R. K., & Zvartau, E. E. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.04.044 · Cited by 34 · see citing works
Nuutinen, S., Ahtee, L., & Tuominen, R. K. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.04.003 · Cited by 33 · see citing works
Self-citationBrown, R. W., Gonzalez, C. L. R., Whishaw, I. Q., & Kolb, B. E. (2001) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00355-7 · Cited by 32 · see citing works
Renda, A., & Nashmi, R. (2014) · BMC Neuroscience · doi:10.1186/1471-2202-15-89 · Cited by 31 · see citing works
Imaging Tobacco Smoking with PET and SPECT
Cosgrove, K., Esterlis, I., Sandiego, C. M., Petrulli, J. R., & Morris, E. D. (2015) · Current topics in behavioral neurosciences · doi:10.1007/978-3-319-13482-6_1 · Cited by 29 · see citing works
Effect of quinpirole on striatal dopamine release and locomotor activity in nicotine-treated mice
Tammimäki, A., Pietilä, K., Raattamaa, H., & Ahtee, L. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.12.027 · Cited by 29 · see citing works
Self-citationMecamylamine decreases accumbal dopamine output in mice treated chronically with nicotine
Gäddnäs, H., Piepponen, P. T., & Ahtee, L. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00734-6 · Cited by 22 · see citing works
Self-citationNuutinen, S., Ekokoski, E., Lahdensuo, E., & Tuominen, R. K. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.06.038 · Cited by 22 · see citing works
Vihavainen, T., Mijatovic, J., Piepponen, P. T., Tuominen, R. K., & Ahtee, L. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.06.004 · Cited by 22 · see citing works
Self-citationGroman, E., & Fagerström, K. O. (2003) · Wiener klinische Wochenschrift · doi:10.1007/bf03040301 · Cited by 20 · see citing works
Salmon, A., Evrard, A., Damaj, M. I., & Changeux, J. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.02.031 · Cited by 20 · see citing works
Tammimäki, A., Chistyakov, V., Patkina, N. A., Skippari, J., Ahtee, L., Zvartau, E. E., & Männistö, P. T. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.06.081 · Cited by 16 · see citing works
Self-citationHerde, A. M., Mihov, Y., Krämer, S. D., Mu, L., Adamantidis, A., Ametamey, S. M., & Hasler, G. (2019) · Neurotoxicity Research · doi:10.1007/s12640-019-00055-5 · Cited by 11 · see citing works
Gäddnäs, H., Pietilä, K., Alila‐Johansson, A., & Ahtee, L. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03603-x · Cited by 11 · see citing works
Self-citationAntidepressants and Smoking Cessation
Gambassi, G., & Bernabei, R. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.11.1257 · Cited by 8 · see citing works
Beer, A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800213-1.00027-4 · Cited by 7 · see citing works
Re-Evaluation of Nicotinic Acetylcholine Receptors in Rat Brain by a Tissue-Segment Binding Assay
Wang, M., Yoshiki, H., Anisuzzaman, A. S. M., Uwada, J., Nishimune, A., Lee, K., Taniguchi, T., & Muramatsu, I. (2011) · Frontiers in Pharmacology · doi:10.3389/fphar.2011.00065 · Cited by 5 · see citing works
Staley, J. K., & Cosgrove, K. (2006) · CRC Press eBooks · doi:10.1201/9781420003468.ch6 · Cited by 1 · see citing works
Tammimäki, A. (2008) · Työväentutkimus Vuosikirja · Cited by 1 · see citing works
Neurochemical Substrates of Habitual Tobacco Smoking
Krishnan‐Sarin, S., Staley, J. K., & Esterlis, I. (2007) · CRC Press eBooks · doi:10.1201/9781420054422.ch3 · Cited by 1 · see citing works
Soll, L. G. (2013) · eScholarship@UMassChan · doi:10.13028/m2ng64
The Term "Lymphangitic Pulmonary Metastases" Resurrected
Hanzlick, R. L., & Björnsson, J. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.11.1254-b
Effects of chronic nicotine on behavioural and neurochemical responses to morphine
Kivinummi, T. (2009) · Työväentutkimus Vuosikirja
Nuutinen, S. (2007) · Työväentutkimus Vuosikirja
EFFECT OF NICOTINE ON DOPAMINERGIC NEUROTRANSMISSION AND EXPRESSION OF FOS PROTEIN
Salminen, O. (2000) · Työväentutkimus Vuosikirja
Upregulation and Functionality of Neuronal Nicotinic Acetylcholine Receptors
Pakkanen, J. S. (2006) · Työväentutkimus Vuosikirja
Woodruff‐Pak, D. S. (2004) · CRC Press eBooks · doi:10.3109/9780203493878-48
de Lima Vieira Brock, P. (2019) · J. Willard Marriott Library · doi:10.26053/0j-t9x7-v964
Long-Term Oral Nicotine Treatment and Daily Variations in Brain Monoamines and Motor Activity
Gäddnäs, H. (2002) · Työväentutkimus Vuosikirja
In Vivo Imaging of Nicotinic Acetylcholine Receptors in the Central Nervous System
Ueda, M., Matsuura, Y., Hosoda, R., & Saji, H. (2018) · Springer eBooks · doi:10.1007/978-981-10-8488-1_2
Kaste, K. (2009) · Työväentutkimus Vuosikirja
- Authors
- Pietilä, K., Lähde, T., Attila, M., Ahtee, L., & Nordberg, A.
- Affiliations
- University of Helsinki (FI)
- Karolinska Institutet (SE)
- ORCID
- Nordberg, Agneta
- Venue
- Naunyn-Schmiedeberg's Archives of Pharmacology
- Published
- 1998-01-28
- Volume
- 357
- Issue
- 2
- Pages
- 176-182
- ISSN
- 0028-1298 (ISSN-L)
- OpenAlex
- W2072854024
- Cited by
- 67
- References
- 33
- Citations by year
- 2021: 1 · 2019: 2 · 2018: 2 · 2016: 1 · 2015: 4 · 2014: 1 · 2013: 2 · 2012: 3
- FWCI
- 1.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Naunyn-Schmiedeberg s Archives of Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Academy of Finland
- Suomen Kulttuurirahasto
- Vetenskapsrådet
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- nicotinic acetylcholine receptors, nicotine withdrawal, chronic nicotine administration, receptor up-regulation, midbrain, cerebral cortex, cerebellum, locomotor depression, tolerance (pharmacology and immunology)
- MeSH terms
- Administration, Oral, Animals, Brain Chemistry, Cerebellum, Cerebral Cortex, Mesencephalon, Motor Activity, Nicotine, Receptors, Nicotinic, Substance Withdrawal Syndrome, Up-Regulation, Nicotinic Agonists, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review